
Cervical cancer technologies emerge to support screening
Cervical cancer is the fourth most frequent cancer in people with a cervix, and in 2018, the World Health Organization (WHO) estimated there were over 500,000 cases, representing approximately 6.6% of all female cancers. According to the American Cancer Society (ACS), 14,000 women are diagnosed with cervical cancer yearly in the US alone, and more than 4,000 women die from it. Due to the high incidence of cervical cancer, the WHO has highlighted an urgent need for effective screening programmes.